PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
The Gut Stuff is a proactive advocate for gut health, educating a substantial community and offering an innovative app in BETA that aims to bridge gaps in the gut health market. With a strong presence in physical products, workplace education, and media, they're positioned to redefine the gut health category and leverage diversified revenue streams for growth during their expansion into the digital realm.
days to go:
Expired
investment:
£321,662
Fore Fitness Group (FFG) is a company that operates the easyGym and PACK45 brands in the fitness space. It operates 20 affordable but high-quality easyGym units across 3 countries. FFG plans to open gyms, boutique studios across the world and develop digital assets such as workout apps. It is developing two new products: an innovative workout app, and an effective & easy-to-use home fitness equipment machine. FFG believes that these steps will appeal to fitness enthusiasts both during and after the Covid-19 pandemic. FFG’s’ vision is to operate the largest fitness network in the world by 2030. The company will use the investment: 10% of it to patent, prototype and gather initial feedback for the home fitness equipment, 20% to build, market and ship the first orders for the home fitness equipment, 15% to market and establish momentum for the workout app, 15% to launch a premium version of the online fitness library, 20% for company costs such as rent and staffing, and the rest for investment opportunities that may present themselves and to seek new Master Franchise Agreements (MFAs) for different countries with eligible partners.
days to go:
Expired
investment:
£1,462,390
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
Lime Global is a UK-based company dedicated to becoming the most customer-focused provider of health cover. Lime argues that conventional health insurance is too expensive and overly complicated. It intends to make health insurance affordable allowing customers to buy the top-ups they want without consulting advisers or filling long questionnaires. Lime Global claims to provide customers with a cancer cover providing a lump sum and support following diagnosis, access to 'Rapid Diagnostics' to avail private diagnostic tests, and an online platform where customers and employers can book and pay for clinical services. Lime Global aspires to become a contender in the UK private healthcare market set to grow more than £8 billion. The company points out that it has secured 5 star Trustpilot reviews over the last year with zero complaints to date. They intend to use the investment to support their expansion into Small and Medium Enterprises (SMEs), mental health modules and e-pharmacies, scale customer acquisition, and support the next stage of its growth in late 2021 and early 2022.
days to go:
Expired
investment:
£474,838
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
BLOK is a multi-disciplinary studio and digital fitness platform. The company's first site in Clapton, Hackney opened in Q1 of 2016, followed by Shoreditch in 2018, and Manchester in 2019. In May 2020, BLOK launched BLOKtv. This launch led to nearly 2,000 people joining BLOK's classes each week with more customers joining in from 134 countries. The digital fitness market has experienced an annual growth of 33% since 2017, and BLOK aims to be the market leader in this segment. The company has hosted global stars such as Anthony Joshua, Jourdan Dunn, Kayla Itsines, Conor Benn and Alicia Vikander. BLOK's studios have also featured on programmes such as 'Britain's Next Top Model' and 'Made in Chelsea'. The company raised over £891,000 from 571 investors on Crowdcube in 2018. It will use the investment to accelerate the growth of BLOKtv and further build its digital community.
days to go:
Expired
investment:
£536,163
Bua Fit is easy to use, a simple way to book web application for outdoor fitness classes. It eliminates all the trouble by connecting the trainers to clients for group fitness classes and gives the customers a diversity of trainers. The company has been a finalist in The Great British Entrepreneurial Challenge, has a network of 100 trainers and 42% active user rate since launch. With the proceeds, the company will earn more users, more trainers, more revenue, invest in product development and expand the team.
days to go:
Expired
investment:
£205,378
